ResMed Stock Options

RMD Stock  USD 279.75  0.29  0.10%   
ResMed's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.21 with a put-to-call open interest ratio of 1.19 over 46 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on October 17th 2025. The total put volume is at 4.0, with calls trading at the volume of 47.0. This yields a 0.09 put-to-call volume ratio.

Open Interest Against October 17th 2025 Option Contracts

The chart above shows ResMed's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ResMed's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ResMed's option, there is no secondary market available for investors to trade.

ResMed Maximum Pain Price Across 2025-10-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as ResMed close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, ResMed's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on ResMed

Analyzing ResMed's in-the-money options over time can help investors to take a profitable long position in ResMed regardless of its overall volatility. This is especially true when ResMed's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ResMed's options could be used as guardians of the underlying stock as they move almost dollar for dollar with ResMed's stock while costing only a fraction of its price.
ResMed's stock options are financial instruments that give investors the right to buy or sell shares of ResMed Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ResMed stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ResMed's stock price goes up or down, the stock options follow.
At present, ResMed's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 8.6 B, whereas Common Stock Total Equity is forecasted to decline to about 417 K.

ResMed Inc In The Money Call Balance

When ResMed's strike price is surpassing the current stock price, the option contract against ResMed Inc stock is said to be in the money. When it comes to buying ResMed's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ResMed Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

ResMed Current Options Market Mood

ResMed's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ResMed Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most ResMed's options investors are not very successful. ResMed's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current ResMed contract

Base on the Rule 16, the options market is currently suggesting that ResMed Inc will have an average daily up or down price movement of about 0.0131% per day over the life of the 2025-10-17 option contract. With ResMed trading at USD 279.75, that is roughly USD 0.0367. If you think that the market is fully incorporating ResMed's daily price movement you should consider buying ResMed Inc options at the current volatility level of 0.21%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing ResMed options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ResMed calls. Remember, the seller must deliver ResMed Inc stock to the call owner when a call is exercised.

ResMed Option Chain

When ResMed's strike price is surpassing the current stock price, the option contract against ResMed Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ResMed's option chain is a display of a range of information that helps investors for ways to trade options on ResMed. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ResMed. It also shows strike prices and maturity days for a ResMed against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
RMD251017C003700000370.00.0 - 1.01.0Out
Call
RMD251017C003600000360.00.0 - 1.01.0Out
Call
RMD251017C0035000012350.00.0 - 0.750.47Out
Call
RMD251017C003400009340.00.0 - 0.750.75Out
Call
RMD251017C003300005330.00.0 - 0.750.7Out
Call
RMD251017C00320000111320.00.0 - 1.950.71Out
Call
RMD251017C00310000171310.00.6 - 1.00.75Out
Call
RMD251017C00300000216300.01.85 - 2.21.75Out
Call
RMD251017C00290000144290.04.2 - 4.74.1Out
Call
RMD251017C0028000045280.08.5 - 9.18.2Out
Call
RMD251017C0027000070270.014.0 - 15.511.12In
Call
RMD251017C00260000323260.021.1 - 24.015.2In
Call
RMD251017C0025000048250.030.0 - 33.429.5In
Call
RMD251017C002400004240.039.5 - 42.723.65In
Call
RMD251017C0023000015230.049.1 - 52.449.1In
Call
RMD251017C002200005220.058.9 - 62.564.5In
Call
RMD251017C002000002200.078.8 - 82.086.5In
Call
RMD251017C001900001190.088.6 - 91.966.0In
Call
RMD251017C001850007185.093.5 - 96.770.7In
 Put
RMD251017P003700000370.089.2 - 92.689.2In
 Put
RMD251017P003600000360.079.4 - 82.679.4In
 Put
RMD251017P003500000350.068.9 - 72.568.9In
 Put
RMD251017P003400000340.059.3 - 62.659.3In
 Put
RMD251017P003300000330.049.2 - 52.149.2In
 Put
RMD251017P003200000320.039.2 - 42.539.2In
 Put
RMD251017P003100000310.029.5 - 32.733.73In
 Put
RMD251017P003000000300.020.5 - 23.520.5In
 Put
RMD251017P0029000065290.012.2 - 14.115.4In
 Put
RMD251017P0028000091280.06.8 - 8.58.6Out
 Put
RMD251017P0027000081270.03.9 - 4.94.7Out
 Put
RMD251017P0026000047260.01.5 - 2.73.12Out
 Put
RMD251017P00250000234250.01.0 - 1.71.5Out
 Put
RMD251017P00240000244240.00.35 - 1.11.05Out
 Put
RMD251017P00230000108230.00.45 - 2.650.75Out
 Put
RMD251017P00220000375220.00.0 - 1.91.4Out
 Put
RMD251017P0021000068210.00.0 - 0.750.4Out
 Put
RMD251017P002000005200.00.1 - 1.71.25Out
 Put
RMD251017P001950002195.00.0 - 0.950.95Out
 Put
RMD251017P001900001190.00.0 - 1.71.7Out
 Put
RMD251017P001850004185.00.0 - 0.950.95Out
 Put
RMD251017P001800003180.00.0 - 1.451.45Out
 Put
RMD251017P001600001160.00.0 - 1.41.4Out
 Put
RMD251017P001550002155.00.0 - 1.61.6Out
 Put
RMD251017P001500002150.00.0 - 0.950.95Out
 Put
RMD251017P0014500075145.00.0 - 0.750.75Out
 Put
RMD251017P001200001120.00.0 - 1.351.35Out

ResMed Total Stockholder Equity

Total Stockholder Equity

6.27 Billion

At present, ResMed's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

ResMed Corporate Directors

Ronald TaylorLead Independent DirectorProfile
Harjit GillIndependent DirectorProfile
Carol BurtIndependent DirectorProfile
Jan WitteIndependent DirectorProfile
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.303
Dividend Share
2.12
Earnings Share
9.5
Revenue Per Share
35.077
Quarterly Revenue Growth
0.102
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.